Furthermore, it underscores the intimate interplay between microenvironmental cues and key oncogenic regulators like ID1, which may collectively drive tumor growth, progression, and therapeutic resistance in pancreatic cancer. This evidence concerns the gene ID1 and pancreatic neoplasm.